Drug Shortage Report for INQOVI
| Report ID | 152829 |
| Drug Identification Number | 02501600 |
| Brand name | INQOVI |
| Common or Proper name | cedazuridine and decitabine |
| Company Name | OTSUKA PHARMACEUTICAL CO LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | |
| Strength(s) | 100MG 35MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | blister |
| ATC code | L01BC |
| ATC description | |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2022-03-15 |
| Actual start date | |
| Estimated end date | 2022-05-20 |
| Actual end date | 2022-05-20 |
| Shortage status | Resolved |
| Updated date | 2022-05-27 |
| Company comments | Manufacturing delay |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2-9 KANDA-TSUKASAMACHI CHIYODA-KU TOKYO, -- JAPAN 101-8535 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v12 | 2022-05-27 | English | Compare |
| v11 | 2022-05-23 | French | Compare |
| v10 | 2022-05-23 | English | Compare |
| v9 | 2022-05-09 | French | Compare |
| v8 | 2022-05-09 | English | Compare |
| v7 | 2022-03-16 | English | Compare |
| v6 | 2022-01-27 | English | Compare |
| v5 | 2022-01-14 | French | Compare |
| v4 | 2022-01-14 | English | Compare |
| v3 | 2022-01-14 | French | Compare |
| v2 | 2022-01-14 | English | Compare |
| v1 | 2022-01-14 | English | Compare |
Showing 1 to 12 of 12